Printer Friendly

TRINITY BIOTECH PLC ANNOUNCES INITIAL PUBLIC OFFERING

 TRINITY BIOTECH PLC ANNOUNCES INITIAL PUBLIC OFFERING
 GALWAY, Ireland, Oct. 21 /PRNewswire/ -- Trinity Biotech plc announced an initial public offering of 300,000 Units ("HIVUF") at $18 (U.S.) each for net proceeds of $4,914,000.
 Each unit consists of Four American Depository Shares representing four common shares ("HIVSY"), two class A warrants ("HIVFW"), each exercisable into one common share and one class B warrant, and one class B warrant ("HIVFZ") exercisable into one common share.
 Dickinson & Co. and Donald & Co., Securities Inc. are the underwriters.
 Trinity is engaged in the development and marketing of rapid diagnostic whole blood and saliva-based tests for the detection of AIDS, hepatitis and other sexually transmitted diseases.
 -0- 10/21/92
 /CONTACT: Anthony Nicholls, Ph.D., 212-832-9292, for Trinity Biotech plc/ CO: Trinity Biotech plc ST: IN: MTC SU: OFR


TM-OS -- NY108 -- 3121 10/21/92 16:56 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 21, 1992
Words:146
Previous Article:PHM CORPORATION REPORTS RECORD THIRD QUARTER NET EARNINGS, EARNINGS PER SHARE AND HOMEBUILDING BACKLOG; CITES GAINS IN MARKET SHARE
Next Article:PAINEWEBBER INCORPORATED ADDS GENERAL MOTORS TO ITS FOCUS LIST
Topics:


Related Articles
TRINITY BIOTECH COMMENCES SHIPMENT OF HIV 1/2 TEST TO INDIA; COMPLETES TRIAL IN BANGLADESH
TRINITY BIOTECH COMMENCES SHIPMENT OF HIV 1/2 SALIVACARD TEST TO THAILAND
TRINITY BIOTECH INITIATES SALES OF SALIVA-BASED AIDS TEST IN SOUTH AMERICA
TRINITY BIOTECH ANNOUNCES EFFECTIVENESS OF REGISTRATION STATEMENT FOR DDI MERGER
TRINITY BIOTECH PLC APPOINTS DR. ANTHONY F. MARTIN PRESIDENT AND DIRECTOR OF AMERICAN OPERATIONS
TRINITY BIOTECH RAISES $1.5 MILLION
TRINITY BIOTECH COMPLETES $3.1 MILLION PRIVATE PLACEMENT
TRINITY BIOTECH AWARDED $500,000 HIV TENDER IN MEXICO
Trinity Biotech Awarded $600,000 by the Irish Trade Board

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters